Pharma

Pharmaceutical strategy aims to boost EU drug discovery and prevent medicines shortages. Some MEPs want to go further and force companies to invest more of their profits in R&D and agree to flexible IP rules. Others say that is ‘tone deaf’

Industry says regulators must intensify preparations for a worst-case scenario. ‘Time is almost up’, warns European Commission president